Ready-made ETF portfolios built for real investor needs. Explore now →
State Street SPDR S&P Biotech ETF
XBI performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 24, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +11.52% | +4.22% | +9.28% | +65.29% | +64.93% | -3.74% |
| Flows | +$314M | -$560M | -$19M | +$404M | -$1.15B | +$839M |
Characteristics
The State Street SPDR S&P Biotech ETF is built to track the S&P Biotechnology Select Industry Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | State Street Investment Management |
| N° of holdings | 151 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | January 31, 2006 |
| ESG | No |
More data and info about XBI on Trackinsight
Exposure
Data as of March 31, 2026Diversification
Total weight of top 15 holdings out of 151
Top 15 Holdings
Sectors
Countries
Latest news about XBI
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +30.22% | +25.87% | +27.40% | +32.69% |
Max drawdown | -7.98% | -9.66% | -32.94% | -55.10% |
Max drawdown duration | 42d | 76d | 331d | 1822d |
Time to recover | 9d | 10d | 183d | N/A |
Replication quality
Data as of March 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is XBI?
XBI is a Passive ETF that provides exposure to Equity assets. It is managed by State Street Investment Management.
What index does XBI track?
XBI tracks the S&P Biotechnology Select Industry Total Return Index - USD, aiming to replicate its performance through full replication.
What does XBI invest in?
This ETF provides exposure to Equally Weighted US Biotechnology Equities. It is part of the segment: US Health Care.
What is the expense ratio of XBI?
The total expense ratio (TER) of XBI is 0.35%, representing the annual fee charged by the fund manager.
When was XBI launched?
XBI was launched on January 31, 2006, marking its entry into the ETF market.
Who is the issuer of XBI?
XBI is issued by State Street Investment Management.
What is the AUM of XBI?
As of April 24, 2026, XBI manages $8.52 B, reflecting the total assets held in the fund.
How has XBI performed recently?
As of April 24, 2026, XBI delivered a return of 11.52% over the past month (1M performance), 4.22% over the past three months (3M), and 9.28% year-to-date (YTD).
What are the recent fund flows for XBI?
As of April 24, 2026, XBI has seen net flows of +$314M in the past month (1M flow) and -$19M year-to-date (YTD).
Does XBI pay dividends?
As of April 24, 2026, XBI has a trailing 12-month distribution yield of 0.33%.
How many holdings are in XBI
As of March 31, 2026, XBI holds 151 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is XBI?
As of March 31, 2026, XBI holds 151 securities, with 19.71% of its assets concentrated in its top 15 holdings.
What are the top holdings of XBI?
As of March 31, 2026, XBI holds a portfolio of 151 underlyings, with its largest positions including APELLIS PHARMACEUTICALS, ALKERMES and MADRIGAL PHARMACEUTICALS INC. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does XBI invest in?
As of March 31, 2026, XBI has its largest geographic exposures in USA.
What sectors or themes does XBI focus on?
As of March 31, 2026, XBI is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
